Holding(s) in Company

Creo Medical Group PLC

28 May 2026

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BZ1BLL44

Issuer Name

CREO MEDICAL GROUP PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

Other

Comments

The percentage change in our holding is a result of the additional shares issued following the completion of the fundraise on 22nd May 2026.

3. Details of person subject to the notification obligation

Name

Development Bank of Wales PLC

City of registered office (if applicable)

Cardiff

Country of registered office (if applicable)

United Kingdom

Name	City of registered office	Country of registered office
Development Bank of Wales PLC	Wrexham	United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

City of registered office (if applicable)

Country of registered office (if applicable)

5. Date on which the threshold was crossed or reached

28-May-2026

6. Date on which Issuer notified

28-May-2026

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	2.922600	0.000000	2.922600	13126727
Position of previous notification (if applicable)	3.977200	0.000000	3.977200

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BZ1BLL44	13126727		2.922600
Sub Total 8.A	13126727		2.922600%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Development Bank of Wales Plc	DBW Investments (6) Ltd	0.428400		0.428400%
Development Bank of Wales Plc	DBW Investments (14) Ltd	0.588300		0.588300%
Development Bank of Wales Plc	DBW Investments (3) Ltd	1.905900		1.905900%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

The percentage change in our holding is a result of the additional shares issued following the completion of the fundraise on 22nd May 2026.

12. Date of Completion

28-May-2026

13. Place Of Completion

Cardiff

 

END